TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Nordic Bioscience A/S
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
500,294
|
351,970
|
469,252 |
| Earnings before taxes |
156,438
|
64,031
|
206,676 |
| Total assets |
654,961
|
433,476
|
406,844 |
| Current assets |
533,003
|
304,268
|
280,374 |
| Current liabilities |
421,051
|
277,620
|
232,034 |
| Equity capital |
171,298
|
91,707
|
107,248 |
| - share capital |
15,397
|
14,888
|
14,965 |
| Employees (average) |
150
|
150
|
150 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
26.2%
|
21.2%
|
26.4% |
| Turnover per employee |
3,335
|
2,346
|
3,128 |
| Profit as a percentage of turnover |
31.3%
|
18.2%
|
44.0% |
| Return on assets (ROA) | |||
| Current ratio |
126.6%
|
109.6%
|
120.8% |
| Return on equity (ROE) |
91.3%
|
69.8%
|
192.7% |
| Change turnover |
136,284
|
-114,879
|
63,684 |
| Change turnover % |
37%
|
-25%
|
16% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.